News

Sai Parenterals secures Rs. 50 crore equity investment from marquee investors: Our Bureau, Bengaluru Tuesday, July 8, 2025, 13:15 Hrs [IST] Sai Parenterals has completed a Rs. 50 ...
Sun Pharma confirms the stocks of 'Levipil 500' seized by Telangana DCA in raids is spurious: Our Bureau, Chennai Tuesday, July 8, 2025, 12:45 Hrs [IST] In a significant regulator ...
In combination with a KRAS inhibitor, HotSpot’s CBM signalosome inhibitor achieved complete suppression of downstream signalling in KRASG12X cell lines. HotSpot’s CBM signalosome inhibitor ...
Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases: Tokyo Tuesday, July 8, 2025, 09:00 Hrs [IST] Chugai Pharmaceu ...
Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies: Vancouver, Canada Tuesday, July 8, 2025, 10:00 Hrs [IST] Onco-Innovations Limited, a Canadian-based c ...
DoC reviews, discusses key issues with stakeholders in exports, imports, trade data and regulations: Shardul Nautiyal, Mumbai Tuesday, July 8, 2025, 08:00 Hrs [IST] In order to ad ...
The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 71 formulations as per the provisions to set prices of new drugs under the Drugs Prices Control Order (DPCO), ...
The National Pharmaceutical Pricing Authority (NPPA) has notified the separate retail price of GlaxoSmithKline (GSK) Asia's cold medicine combination paracetamol 500 mg and phenylephrine HCl 10 mg at ...
India and Uzbekistan eye strategic pharma collaboration to strengthen bilateral trade: Shardul Nautiyal, Mumbai Tuesday, July 8, 2025, 08:00 Hrs [IST] In a significant move toward ...
FOPE president asks MSMEs to implement revised Schedule M as govt unlikely to extend deadline: Peethaambaran Kunnathoor, Chennai Tuesday, July 8, 2025, 08:00 Hrs [IST] The preside ...
InnoCare receives China NMPA approval to conduct clinical trial of a novel B7-H3 targeted ADC ICP-B794: Beijing Monday, July 7, 2025, 15:00 Hrs [IST] InnoCare Pharma, a leading bi ...